These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15622982)

  • 1. [Characteristics of pediatric tuberculosis].
    Med Mal Infect; 2004; 34(8-9):382-5. PubMed ID: 15622982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis treatment today].
    Nowak D; Radenbach D; Kirsten D; Magnussen H
    Z Gesamte Inn Med; 1991 Aug; 46(10-11):404-9. PubMed ID: 1926948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of tuberculosis-disease].
    Med Mal Infect; 2004; 34(8-9):375-81. PubMed ID: 15622981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Mukherjee A; Velpandian T; Singla M; Kanhiya K; Kabra SK; Lodha R
    Int J Tuberc Lung Dis; 2016 May; 20(5):666-72. PubMed ID: 27084822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance.
    Reves R; Heilig CM; Tapy JM; Bozeman L; Kyle RP; Hamilton CD; Bock N; Narita M; Wing D; Hershfield E; Goldberg SV;
    Int J Tuberc Lung Dis; 2014 May; 18(5):571-80. PubMed ID: 24903795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children.
    Ramachandran G; Hemanth Kumar AK; Bhavani PK; Poorana Gangadevi N; Sekar L; Vijayasekaran D; Banu Rekha VV; Ramesh Kumar S; Ravichandran N; Mathevan G; Swaminathan S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):800-6. PubMed ID: 23676165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemotherapy of tuberculous meningitis in children and adults.
    Donald PR
    Tuberculosis (Edinb); 2010 Nov; 90(6):375-92. PubMed ID: 20810322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].
    Grosset J; Truffot C; Fermanian J; Lecoeur H
    Pathol Biol (Paris); 1982 Jun; 30(6):444-8. PubMed ID: 6810288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental short-course preventive therapy of tuberculosis with rifampin and pyrazinamide.
    Lecoeur HF; Truffot-Pernot C; Grosset JH
    Am Rev Respir Dis; 1989 Nov; 140(5):1189-93. PubMed ID: 2817579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum concentrations of anti-tuberculosis drugs and determinants of their serum levels.
    Um SW; Lee SW; Kwon SY; Yoon HI; Park KU; Song J; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):972-8. PubMed ID: 17705974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short-term chemotherapy of tuberculosis in children].
    Hussein A
    Pneumologie; 1990 Jan; 44(1):24-31. PubMed ID: 2408034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of combined therapy of oral anti-tubercular agents on theophylline pharmacokinetics.
    Ahn HC; Yang JH; Lee HB; Rhee YK; Lee YC
    Int J Tuberc Lung Dis; 2000 Aug; 4(8):784-7. PubMed ID: 10949332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment results of patients with bacteriologically confirmed tuberculosis registered in Poland in 1996].
    Szczuka I; Masztalerz J
    Pneumonol Alergol Pol; 1999; 67(7-8):336-46. PubMed ID: 10647285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of extrapulmonary tuberculosis.
    Dutt AK; Stead WW
    Semin Respir Infect; 1989 Sep; 4(3):225-31. PubMed ID: 2688005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pyrazinamide versus ethambutol in short-term therapy of lung tuberculosis. A randomized study].
    Fiala W; Häcki MA; Brändli O
    Schweiz Med Wochenschr; 1983 Dec; 113(51):1956-9. PubMed ID: 6658432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India.
    Hemanth Kumar AK; Kannan T; Chandrasekaran V; Sudha V; Vijayakumar A; Ramesh K; Lavanya J; Swaminathan S; Ramachandran G
    Int J Tuberc Lung Dis; 2016 Sep; 20(9):1236-41. PubMed ID: 27510252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity of anti-tuberculosis chemotherapy in patients with liver cirrhosis.
    Shin HJ; Lee HS; Kim YI; Lim SC; Jung JP; Ko YC; Kwon YS
    Int J Tuberc Lung Dis; 2014 Mar; 18(3):347-51. PubMed ID: 24670574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
    Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.